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Multifunctionalized 4H-pyrans have received considerable
attention in previous years owing to wide range of useful
biological and pharmacological properties such as anti-
coagulant, anticancer, spasmolytic, and anti-anaphylactic
activities (Foye, 1991; Green et al., 1995; Hatakeyama et al.,1988; Kang et al., 2009; Rong et al., 2006). These compounds
can be employed as pigments (Ellis, 1977), photoactive
materials (Armesto et al., 1989) and utilized as potential biode-
gradable agrochemicals (Abdelgalil et al., 1982; Hafez et al.,
1987). Furthermore, 2-amino-4H-pyrans are useful for
preparation of difﬁcultly accessible annulated heterocycles
(O´Callaghan et al., 1995).
Several methods are available for the synthesis of 4H-pyrans
especially 2-amino-4H-pyrans involving the bicomponent con-
densation of a-cyanocinnamonitriles with dimedone (Seiﬁ and
Sheiban, 2008) or b-naphthol (Wang et al., 2008), three-compo-
nent reaction of aldehydes, malononitrile or ethyl cyanoacetate
with dimedone (Wang et al., 2006), ethylacetoacetate
(Valizadeh and Azimi, 2011), 4-hydroxycoumarin, 4-hydroxy-
6-methylpyrone (Khurana et al., 2010) and active phenols
(Gong et al., 2008). The other synthetic method for preparation
of 2-amino-4H-pyran derivatives was achieved by the Michael
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400 A. Mobinikhaledi et al.addition-cyclization reaction of a,b-unsaturated carbonyl
compound with malononitrile (Zhao et al., 2009; Zhou, 2003;
Kumar et al., 2007, 2011). However, some of these methods
suffer from one or more disadvantages such as use of toxic or-
ganic solvents or toxic catalyst (such as piperidine (Zhou,
2003)), strong bases for example sodium ethoxide (Kumar
et al., 2007), special reagents/apparatus, and often expensive
catalysts. Although several methods for the synthesis of 4H-
pyran derivatives have been reported, there is still a demand
for simple and facile procedures for the preparation of these
compounds using a cheap and readily available catalyst.
2. Results and discussion
As a part of our continued interest in the development of prac-
tical, safe and environmentally friendly procedures for some
important transformations (Foroughifar et al., 2009, 2010,
2011; Mobinikhaledi et al., 2011), we report here a convenient
and facile method for the synthesis of 4H-pyran derivatives 5
via a bicomponent reaction of a,a0-bis(substituted-benzyli-
dene) cycloalkanones 3 and malononitrile 4 in the presence
of piperazine under reﬂux conditions (Scheme 1).
a,a0-Bis(substituted-benzylidene) cycloalkanone derivatives
3 were prepared from Cross-Aldol condensation of cyclic ke-
tones 1 with various aromatic aldehydes 2 bearing electron-
withdrawing groups (such as nitro, halide), electron-releasing
groups (such as methyl, methoxy), according to the reported
procedures (Scheme 2) (Cai et al., 2006; Singh et al., 2009).
In order to optimize the reaction conditions, some polar
and non polar solvents in the presence of piperazine have been
used in reaction of 2,6-dibenzylidenecyclohexanone 3a with
malononitrile 4 as a model reaction to investigate the effects
of solvent for preparing compound 5a (Table 1). It is notewor-
thy to mention that the polar solvents such as methanol and
ethanol or acetonitrile, afforded the better yields than nonpo-
lar ones, and ethanol is the most effective solvent. In addition,
increasing the loading of the catalyst to 20 mol% gave no
improvement in the yield of 5a, while reaction with 5 mol%
of catalyst needed longer reaction time (Table 1, entry 8).
After determining the optimized reaction conditions, we
turned our attention toward studying the scope of this reaction
to test the generality of this method. Thus, various 2,6-diben-
zylidenecyclohexanone derivatives with both activating and
deactivating groups such as Me, OMe, F, Cl, and NO2 were
treated under the optimized conditions and afforded the corre-
sponding 4H-pyran derivatives in good yields. To extend the
preparative utility and generality of this reaction a variety of
2,5-dibenzylidenecyclopentanone derivatives were treated with
malononitrile under the same experimental conditions and cor-
responding products were obtained in good yields without any
difﬁculties (Table 2). The results clearly indicate that reactions
can tolerate a wide range of differently substituted a,a0-bis(substituted-benzylidene) cycloalkanones 3, and substitu-
ents on the aromatic ring did not show any electronic effects
in terms of yields under these reaction conditions.
3. Conclusion
In conclusion, we have developed a low-cost, convenient pro-
cedure for the synthesis of 4H-pyran derivatives by a one-step
condensation reaction of a,a0-bis(substituted benzylidene)
cycloalkanones and malononitrile in the presence of piperazine
under organic conditions.
4. Experimental
4.1. General experimental section
All products were characterized by a comparison of their spec-
tral (IR, 1H NMR, and 13C NMR) data. Melting points were
measured by using capillary tubes on an electro thermal digital
apparatus and are uncorrected. IR spectra were recorded on a
galaxy series FT-IR 5000 spectrometer in KBr pellet. 1H NMR
and 13C NMR spectra were obtained from a solution in
DMSO-d6 with Me4Si as internal standard using Brucker spec-
trophotometer (300 MHz).
4.2. General procedure for preparation of
A mixture of a,a0-bis(substituted benzylidene) cycloalkanones
(1 mmol), malononitrile (1.5 mmol), piperazine (10 mol%)
and 5 mL of ethanol was stirred magnetically under reﬂux con-
ditions for appropriate time as mentioned in Table 2. After
completion of the reaction as monitored by TLC, reaction
mixture was cooled to room temperature and 10 mL of water
was added to it. The solid product obtained was ﬁltered and
dried. The crude product was recrystallized from ethanol to
yield pure product.
4.2.1. Spectral data
4.2.1.1. Compound 5a (Table 2, entry 1). IR (KBr):
mmax = 3432, 3338, 3025, 2916, 2845, 2189, 1670, 1620, 1512,
1413, 1267, 1145, 1053, 700 cm1; 1H NMR (300 MHz,
DMSO-d6): d= 7.41–7.19 (m, 10H, ArH), 6.97 (s, 1H,
C‚CH), 6.81 (s, 2H, NH2), 3.97 (s, 1H, CH), 2.65–2.60 (m,
1H, CH2), 2.50–2.46 (m, 1H, CH2), 2.06–2.02 (m, 1H, CH2)
1.85–1.80 (m, 1H, CH2), 1.53–1.49 (m, 2H, CH2);
13C NMR
(75 MHz, DMSO-d6): d= 160.3, 144.4, 141.1, 137.2, 129.8,
129.5, 129.1, 128.8, 128.1, 127.4, 127.2, 122.6, 121.1, 116.0,
56.2 (C-CN), 43.6 (CH), 27.2 (CH2), 26.9 (CH2), 22.3 (CH2);
Anal. Calcd for C23H20N2O: C, 81.15; H, 5.92; N, 8.23.
Found: C, 80.97; H, 6.32; N, 8.17.
Table 1 Optimization of reaction conditions.
Entry Conditions Piperazine (mol%) Time (h) Yielda (%)
1 Toluene/Reﬂux 10 6 53
2 CH3OH/Reﬂux 10 3 76
3 CH3CN/Reﬂux 10 3 73
4 CHCl3/Reﬂux 10 4 65
5 CCl4/Reﬂux 10 6 56
6 C2H5OH/R.T. 10 12 48
7 C2H5OH/Reﬂux 5 6 74
8 C2H5OH/Reﬂux 10 2.5 80
9 C2H5OH/Reﬂux 20 2.5 80
a Isolated yields.
Table 2 Synthesis of 4H-pyran derivatives.
Entry Ar n Product Time (h) Yielda (%) M.P (C)
1 C6H5 2 5a 2.5 80 250–251
2 3,4-(MeO)2 C6H3 2 5b 5 71 200–202
3 4-Me C6H4 2 5c 4 75 191–193
4 2-MeO C6H4 2 5d 6 62 181–183
5 4-Cl C6H4 2 5e 3.5 82 232–234
6 3-NO2 C6H4 2 5f 5 81 265–266
7 2-Cl C6H4 2 5g 4 65 240–242
8 2-Cl-6-F C6H3 2 5h 6 73 237–238
9 C6H5 1 5i 3 78 235–236
10 3,4-(MeO)2 C6H3 1 5j 6 65 186–187
11 2-Cl-6-F C6H3 1 5k 5 72 268–270
12 2-MeO C6H4 1 5l 5 66 185–187
a Isolated yields.
Piperazine catalyzed convenient synthesis of 4H-pyran derivatives 4014.2.1.2. Compound 5b (Table 2, entry 2). IR (KBr):
mmax = 3396, 3329, 2966, 2185, 1667, 1607, 1512, 1462, 1417,
1248, 1134, 1024, 891, 781 cm1; 1H NMR (300 MHz,
DMSO-d6): d= 6.97–6.86 (m, 5H, ArH), 6.77–6.71 (m, 2H,
ArH, C‚CH), 6.68 (s, 2H, NH2), 3.91 (s, 1H, CH), 3.76 (s,
6H, OCH3), 3.74 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 2.71–
2.65 (m, 1H, CH2), 2.54–2.50 (m, 1H, CH2), 2.06–2.00 (m,
1H, CH2) 1.85–1.79 (m, 1H, CH2), 1.56–1.49 (m, 2H, CH2);
13C NMR (75 MHz, DMSO-d6): d= 160.2, 149.2, 148.8,
148.3, 141.1, 137.0, 130.0, 128.3, 122.4, 122.2, 121.2, 120.1,
115.3, 113.3, 112.5, 122.1, 111.9, 56.6 (C-CN), 56.0 (OCH3),
55.9 (OCH3), 55.8 (OCH3), 43.2 (CH), 27.2 (CH2), 27.1
(CH2), 22.4 (CH2). Anal. Calcd for C27H28N2O5: C, 70.42;
H, 6.13; N, 6.08. Found: C, 70. 28; H, 6.21; N, 6.03.
4.2.1.3. Compound 5c (Table 2, entry 3). IR (KBr):
mmax = 3445, 3333, 3040, 2918, 2195, 1667, 1638, 1601, 1508,
1406, 1253, 1126, 1040, 879 cm1; 1H NMR (300 MHz,
DMSO-d6): d= 7.20–7.08 (m, 8H, ArH), 6.93 (s, 1H,
C‚CH), 6.78 (s, 2H, NH2), 3.90 (s, 1H, CH), 2.61–2.58 (m,
1H, CH2), 2.49–2.45 (m, 1H, CH2), 2.28 (s, 6H, CH3), 2.04–
1.97 (m, 1H, CH2) 1.80–1.75 (m, 1H, CH2), 1.48 (s, 2H,
CH2);
13C NMR (75 MHz, DMSO-d6): d= 160.2, 141.5,
141.0, 136.5, 134.4, 129.6, 129.5, 129.4, 129.1, 128.0, 122.4,
121.1, 115.7, 56.5 (C-CN), 43.3 (CH), 27.2 (CH2), 27.0
(CH2), 22.3 (CH2), 21.2 (CH3), 21.1 (CH3); Anal. Calcd for
C25H24N2O: C, 81.49; H, 6.57; N, 7.60. Found: C, 81.31; H,
6.53; N, 7.65.4.2.1.4. Compound 5d (Table 2, entry 4). IR (KBr):
mmax = 3458, 3347, 2935, 2835, 2189, 1672, 1634, 1597,
1489, 1462, 1246, 1128, 1026, 754 cm1; 1H NMR
(300 MHz, DMSO-d6): d= 7.25–7.19 (m, 3H, ArH), 7.08 (s,
1H, C‚CH), 7.02–6.93 (m, 5H, ArH), 6.67 (s, 2H, NH2),
4.45 (s, 1H, CH), 3.80 (s, 6H, OCH3), 2.42–2.37 (m, 1H,
CH2), 2.08–1.94 (m, 2H, CH2), 1.80–1.75 (m, 1H, CH2)
1.51–1.44 (m, 2H, CH2);
13C NMR (75 MHz, DMSO-d6):
d= 160.9, 157.4, 157.3, 141.5, 132.4, 130.4, 129.6, 129.0,
128.9, 128.5, 125.8, 121.5, 121.2, 120.3, 118.5, 115.7, 111.8,
111.2, 56.2 (C-CN), 55.8 (OCH3), 55.6 (OCH3), 35.6 (CH),
27.2 (CH2), 27.1(CH2), 22.4 (CH2); Anal. Calcd for
C25H24N2O3: C, 74.98; H, 6.04; N, 7.00. Found: C, 75.11;
H, 6.10; N, 6.93.
4.2.1.5. Compound 5e (Table 2, entry 5). IR (KBr):
mmax = 3454, 3315, 2187, 1672, 1632, 1597, 1487, 1410, 1263,
1134, 1013, 895, 823 cm1; 1H NMR (300 MHz, DMSO-d6):
d= 7.45–7.40 (m, 4H, ArH), 7.32 (d, J = 8.3 Hz, 2H, ArH),
7.23 (d, J = 8.2 Hz, 2H, ArH), 6.94 (s, 1H, C‚CH), 6.82 (s,
2H, NH2), 4.02 (s, 1H, CH), 2.64–2.59 (m, 1H, CH2), 2.50–
2.46 (m, 1H, CH2), 2.05–2.00 (m, 1H, CH2) 1.79–1.74 (m,
1H, CH2), 1.53 (s, 2H, CH2);
13C NMR (75 MHz, DMSO-
d6): d= 160.3, 143.4, 141.0, 136.0, 132.0, 131.9, 131.2, 130.5,
129.9, 129.1, 128.8, 121.4, 120.9, 116.0, 55.8 (C-CN), 42.9
(CH), 27.1 (CH2), 26.8 (CH2), 22.2 (CH2); Anal. Calcd for
C23H18Cl2N2O: C, 67.49; H, 4.43; N, 6.84. Found: C, 67.34;
H, 4.52; N, 6.95.
402 A. Mobinikhaledi et al.4.2.1.6. Compound 5f (Table 2, entry 6). Yield 81%; time 5 h;
mp = 265–266 C; IR (KBr): mmax = 3439, 3331, 3219, 2930,
2193, 1676, 1645, 1605, 1520, 1419, 1350, 1136, 1041, 812,
731 cm1; 1H NMR (300 MHz, DMSO-d6): d= 8.16–8.06
(m, 4H, ArH), 7.77–7.68 (m, 4H, ArH), 7.09 (s, 1H, C‚CH),
6.97 (s, 2H, NH2), 4.31 (s, 1H, CH), 2.73–2.68 (m, 1H, CH2),
2.55–2.50 (m, 1H, CH2), 2.10–2.05 (m, 1H, CH2) 1.81–1.75 (m,
1H, CH2), 1.57 (s, 2H, CH2);
13C NMR (75 MHz, DMSO-d6):
d= 160.5, 148.5, 148.3, 146.6, 141.2, 138.7, 135.7, 134.9,
132.1, 130.9, 130.3, 123.8, 122.7, 122.5, 121.9, 120.9, 120.6,
116.5, 55.4 (C-CN), 43.1 (CH), 27.0 (CH2), 26.7 (CH2), 22.1
(CH2); Anal. Calcd for C23H18N4O5: C, 64.18; H, 4.22; N,
13.02. Found: C, 64.31; H, 4.31; N, 12.94.
4.2.1.7. Compound 5g (Table 2, entry 7). IR (KBr):
mmax = 3464, 3345, 3055, 2920, 2191, 1670, 1637, 1595, 1468,
1414, 1255, 1130, 1034, 748 cm1; 1H NMR (300 MHz,
DMSO-d6): d= 7.50–7.27 (m, 8H, ArH), 6.99 (s, 1H,
C‚CH), 6.94 (s, 2H, NH2), 4.58 (s, 1H, CH), 2.45–2.34 (m,
2H, CH2), 2.09–2.02 (m, 1H, CH2), 1.74–1.68 (m, 1H, CH2),
1.50–1.45 (m, 2H, CH2);
13C NMR (75 MHz, DMSO-d6):
d= 160.6, 141.3, 141.2, 135.3, 133.4, 132.9, 131.5, 131.4,
130.9, 129.9, 129.8, 129.2, 128.5, 127.3, 120.7, 119.9, 115.8,
55.1 (C-CN), 40.1 (CH), 27.1 (CH2), 27.0 (CH2), 22.2 (CH2);
Anal. Calcd for C23H18Cl2N2O: C, 67.49; H, 4.43; N, 6.84.
Found: C, 67.41; H, 4.50; N, 6.78.
4.2.1.8. Compound 5h (Table 2, entry 8). IR (KBr):
mmax = 3455, 3344, 2941, 2189, 1674, 1640, 1599, 1442, 1242,
1132, 901, 783 cm1; 1H NMR (300 MHz, DMSO-d6):
d= 7.38–7.23 (m, 6H, ArH), 6.90 (s, 2H, NH2), 6.64 (s, 1H,
C‚CH), 4.80 (s, 1H, CH), 2.15–2.02 (m, 3H, CH2), 1.80–
1.72 (m, 1H, CH2), 1.51 (s, 2H, CH2);
13C NMR (75 MHz,
DMSO-d6): d= 161.4, 161.1, 158.1, 141.2, 134.4, 134.3,
134.1, 130.4, 130.3, 125.8, 124.2, 123.9, 120.6, 115.9, 115.2,
114.9, 113.1, 52.6 (C-CN), 40.2 (CH), 27.5 (CH2), 27.0
(CH2), 21.9 (CH2); Anal. Calcd for C23H16Cl2F2N2O: C,
62.04; H, 3.62; N, 6.29. Found: C, 61.90; H, 3.67; N, 6.19.
4.2.1.9. Compound 5i (Table 2, entry 9). IR (KBr):
mmax = 3447, 3331, 3248, 3204, 3020, 2918, 2845, 2197, 1684,
1643, 1587, 1450, 1383, 1109, 1043, 869, 756, 700 cm1; 1H
NMR (300 MHz, DMSO-d6): d= 7.37–7.7.33 (m, 5H, ArH),
7.28–7.19 (m, 5H, ArH), 6.94 (s, 2H, NH2), 6.38 (s, 1H,
C‚CH), 4.28 (s, 1H, CH), 2.80 (s, 2H, CH2), 2.36–2.30 (m,
1H, CH2), 2.10–1.98 (m, 1H, CH2);
13C NMR (75 MHz,
DMSO-d6): d= 161.2, 146.0, 143.1, 138.0, 137.4, 129.4,
129.1, 128.4, 128.1, 127.6, 126.9, 122.8, 121.1, 116.6, 56.3 (C-
CN), 41.1 (CH), 28.1 (CH2), 26.9 (CH2); Anal. Calcd for
C22H18N2O: C, 80.96; H, 5.56; N, 8.58. Found: C, 81.05; H,
5.64; N, 8.51.
4.2.1.10. Compound 5j (Table 2, entry 10). IR (KBr):
mmax = 3400, 3329, 3211, 2939, 2179, 1684, 1637, 1593, 1512,
1462, 1421, 1250, 1134, 1026, 887, 771 cm1; 1H NMR
(300 MHz, DMSO-d6): d= 6.95–6.85 (m, 6H, ArH), 6.75 (s,
2H, NH2), 6.32 (s, 1H, C‚CH), 4.20 (s, 1H, CH), 3.73 (s,
12H, OCH3), 2.86–2.78 (m, 2H, CH2), 2.35–2.30 (m, 1H,
CH2), 2.12–2.06 (m, 1H, CH2);
13C NMR (75 MHz, DMSO-
d6): d= 161.1, 149.2, 149.1, 148.3, 148.1, 146.0, 135.7, 130.5,
121.7, 121.1, 120.1, 116.5, 112.4, 111.9, 111.8, 56.8 (C-CN),
56.0 (OCH3), 55.8 (OCH3), 28.1 (CH2), 26.7 (CH2); Anal.Calcd for C26H26N2O5: C, 69.94; H, 5.87; N, 6.27. Found:
C, 69.85; H, 5.95; N, 6.18.
4.2.1.11. Compound 5k (Table 2, entry 11). IR (KBr):
mmax = 3481, 3331, 3210, 2911, 2197, 1689, 1643, 1597, 1445,
1377, 1242, 1107, 1038, 895, 781 cm1; 1H NMR (300 MHz,
DMSO-d6): d= 7.41–7.21 (m, 6H, ArH), 7.04 (s, 2H, NH2),
6.26 (s, 1H, C‚CH), 4.98 (s, 1H, CH), 2.45 (s, 2H, CH2),
2.36–2.29 (m, 1H, CH2), 2.02–1.96 (m, 1H, CH2)
13C NMR
(75 MHz, DMSO-d6): d= 161.4, 158.1, 146.2, 142.8, 134.2,
134.1, 130.6, 130.5, 130.0, 129.9, 125.8, 123.9, 123.7, 122.3,
120.5, 115.4, 115.1, 107.1, 53.4 (C-CN), 35.4 (CH),
27.3 (CH2), 26.2 (CH2); Anal. Calcd for C22H14Cl2F2N2O:
C, 61.27; H, 3.27; 8.81; N, 6.50. Found: C, 61.15; H, 3.36;
N, 6.46.
4.2.1.12. Compound 5l (Table 2, entry 12). IR (KBr):
mmax = 3331, 3211, 3061, 2914, 2193, 1682, 1640, 1593, 1487,
1464, 1365, 1236, 1101, 1030, 748 cm1; 1H NMR (300 MHz,
DMSO-d6): d= 7.39–7.09 (m, 5H, ArH), 6.99–6.92 (m, 5H,
ArH, NH2), 6.68 (s, 1H, C‚CH), 4.69 (s, 1H, CH), 3.72 (s,
6H, OCH3), 2.72 (s, 2H, CH2), 2.35–2.30 (m, 1H, CH2),
2.03–1.98 (m, 1H, CH2);
13C NMR (75 MHz, DMSO-d6):
d= 161.9, 157.2, 156.8, 146.5, 137.4, 130.8, 128.9, 128.6,
128.3, 128.0, 126.1, 122.4, 121.4, 121.2, 120.7, 111.6, 111.3,
110.6, 56.0 (C-CN), 55.8 (OCH3), 55.4 (OCH3), 33.9 (CH),
28.1 (CH2), 26.7 (CH2); Anal. Calcd for C24H22N2O3: C,
74.59; H, 5.74; N, 7.25. Found: C, 74.69; H, 5.81; N, 7.14.Acknowledgment
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